Aeglea BioTherapeutics is a startup.
Aeglea BioTherapeutics is a startup.
Aeglea BioTherapeutics develops engineered human enzymes as novel therapies for rare genetic and metabolic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.